1887

Chapter 15 : Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818791/9781555818784_Chap15-1.gif /docserver/preview/fulltext/10.1128/9781555818791/9781555818784_Chap15-2.gif

Abstract:

Shiga toxin (Stx)-producing (STEC) cause illness with a spectrum of severity ranging from mild (even asymptomatic) carriage to life-threatening disease ( ). STEC infections are relatively uncommon; in the United States, extrapolation of data from FoodNet ( ) to a nationwide population that exceeds 300,000,000 indicates there are fewer than 4,000 diagnosed cases of O157:H7 infection per annum. O157:H7 remains the near-exclusive cause of hemolytic-uremic syndrome (HUS) throughout most of the world, and the single serotype on which most data have been generated. Therefore, we emphasize this particular pathogen in this article. The European Food Safety Authority and the European Centre for Disease Prevention and Control report similar epidemiology: 4,000 confirmed infections caused by Stx-producing strains (mostly belonging to the O157 serogroup) in 27 European Union member states. The number of reported infections attributed to strains that produce Shiga toxins has increased since 2008 ( ).

Citation: Davis T, van De Kar N, Tarr P. 2015. Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives, p 321-339. In Sperandio V, Hovde C (ed), Enterohemorrhagic and Other Shiga Toxin-Producing . ASM Press, Washington, DC. doi: 10.1128/microbiolspec.EHEC-0025-2014
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818791.chap15
1. Denno DM,, Shaikh N,, Stapp JR,, Qin X,, Hutter CM,, Hoffman V,, Mooney JC,, Wood KM,, Stevens HJ,, Jones R,, Tarr PI,, Klein EJ . 2012. Diarrhea etiology in a pediatric emergency department: a case control study. Clin Infect Dis 55 : 897 904.[PubMed] [CrossRef]
2. Watanabe H,, Terajima J,, Izumiya H,, Wada A,, Tamura K . 1999. Molecular analysis of enterohemorrhagic Escherichia coli isolates in Japan and its application to epidemiological investigation. Pediatr Int 41 : 202 208.[PubMed] [CrossRef]
3. Stephan R,, Untermann F . 1999. Virulence factors and phenotypical traits of verotoxin-producing Escherichia coli strains isolated from asymptomatic human carriers. J Clin Microbiol 37 : 1570 1572.[PubMed]
4. Gould LH,, Mody RK,, Ong KL,, Clogher P,, Cronquist AB,, Garman KN,, Lathrop S,, Medus C,, Spina NL,, Webb TH,, White PL,, Wymore K,, Gierke RE,, Mahon BE,, Griffin PM , Emerging Infections Program Foodnet Working Group . 2013. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000–2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 10 : 453 460.[PubMed] [CrossRef]
5. European Food Safety Authority . 2012. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010. EFSA Journal 10 : 161188.
6. Konowalchuk J,, Speirs JI,, Stavric S . 1977. Vero response to a cytotoxin of Escherichia coli . Infect Immun 18 : 775 779.[PubMed]
7. Karmali MA,, Steele BT,, Petric M,, Lim C . 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1 : 619 620.[PubMed] [CrossRef]
8. Miceli S,, Jure MA,, de Saab OA,, de Castillo MC,, Rojas S,, de Holgado AP,, de Nader OM . 1999. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina. Jpn J Infect Dis 52 : 33 37.[PubMed]
9. Brandt JR,, Fouser LS,, Watkins SL,, Zelikovic I,, Tarr PI,, Nazar-Stewart V,, Avner ED . 1994. Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr 125 : 519 526.[PubMed] [CrossRef]
10. Riley LW,, Remis RS,, Helgerson SD,, McGee HB,, Wells JG,, Davis BR,, Hebert RJ,, Olcott ES,, Johnson LM,, Hargrett NT,, Blake PA,, Cohen ML . 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308 : 681 685.[PubMed] [CrossRef]
11. Meites S,, Buffone GJ . 1989. Pediatric Clinical Chemistry: Reference (Normal) Values. AACC Press, Washington, DC.
12. Banatvala N,, Griffin PM,, Greene KD,, Barrett TJ,, Bibb WF,, Green JH,, Wells JG , Hemolytic Uremic Syndrome Study Collaborators . 2001. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183 : 1063 1070.[PubMed] [CrossRef]
13. Tsai HM,, Chandler WL,, Sarode R,, Hoffman R,, Jelacic S,, Habeeb RL,, Watkins SL,, Wong CS,, Williams GD,, Tarr PI . 2001. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49 : 653 659.[PubMed] [CrossRef]
14. Jelacic S,, Wobbe CL,, Boster DR,, Ciol MA,, Watkins SL,, Tarr PI,, Stapleton AE . 2002. ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections. J Infect Dis 185 : 214 219.[PubMed] [CrossRef]
15. Cornick NA,, Jelacic S,, Ciol MA,, Tarr PI . 2002. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome. J Infect Dis 186 : 57 63.[PubMed] [CrossRef]
16. Klein EJ,, Stapp JR,, Clausen CR,, Boster DR,, Wells JG,, Qin X,, Swerdlow DL,, Tarr PI . 2002. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141 : 172 177.[PubMed] [CrossRef]
17. Smith JM,, Jones F,, Ciol MA,, Jelacic S,, Boster DR,, Watkins SL,, Williams GD,, Tarr PI,, Henderson WR Jr . 2002. Platelet-activating factor and Escherichia coli O157:H7 infections. Pediatr Nephrol 17 : 1047 1052.[PubMed] [CrossRef]
18. Thayu M,, Chandler WL,, Jelacic S,, Gordon CA,, Rosenthal GL,, Tarr PI . 2003. Cardiac ischemia during hemolytic uremic syndrome. Pediatr Nephrol 18 : 286 289.[PubMed]
19. Jelacic JK,, Damrow T,, Chen GS,, Jelacic S,, Bielaszewska M,, Ciol M,, Carvalho HM,, Melton-Celsa AR,, O’Brien AD,, Tarr PI . 2003. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 188 : 719 729.[PubMed] [CrossRef]
20. Ake JA,, Jelacic S,, Ciol MA,, Watkins SL,, Murray KF,, Christie DL,, Klein EJ,, Tarr PI . 2005. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115 : e673 e680.[PubMed] [CrossRef]
21. Hickey CA,, Beattie TJ,, Cowieson J,, Miyashita Y,, Strife CF,, Frem JC,, Peterson JM,, Butani L,, Jones DP,, Havens PL,, Patel HP,, Wong CS,, Andreoli SP,, Rothbaum RJ,, Beck AM,, Tarr PI . 2011. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 165 : 884 889.[PubMed] [CrossRef]
22. Zimmerhackl LB,, Rosales A,, Hofer J,, Riedl M,, Jungraithmayr T,, Mellmann A,, Bielaszewska M,, Karch H . 2010. Enterohemorrhagic Escherichia coli O26:H11-associated Hemolytic uremic syndrome: bacteriology and clinical presentation. Semin Thromb Hemost 36 : 586 593.[PubMed] [CrossRef]
23. Gerber A,, Karch H,, Allerberger F,, Verweyen HM,, Zimmerhackl LB . 2002. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis 186 : 493 500.[PubMed] [CrossRef]
24. Bielaszewska M,, Middendorf B,, Kock R,, Friedrich AW,, Fruth A,, Karch H,, Schmidt MA,, Mellmann A . 2008. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 47 : 208 217.[PubMed] [CrossRef]
25. Bielaszewska M,, Kock R,, Friedrich AW,, von Eiff C,, Zimmerhackl LB,, Karch H,, Mellmann A . 2007. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2 : e1024. [PubMed] [CrossRef]
26. Friedrich AW,, Zhang W,, Bielaszewska M,, Mellmann A,, Kock R,, Fruth A,, Tschape H,, Karch H . 2007. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45 : 39 45.[PubMed] [CrossRef]
27. Bielaszewska M,, Friedrich AW,, Aldick T,, Schurk-Bulgrin R,, Karch H . 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 43 : 1160 1167.[PubMed] [CrossRef]
28. Sonntag AK,, Prager R,, Bielaszewska M,, Zhang W,, Fruth A,, Tschape H,, Karch H . 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J Clin Microbiol 42 : 954 962.[PubMed] [CrossRef]
29. Ikeda K,, Ida O,, Kimoto K,, Takatorige T,, Nakanishi N,, Tatara K . 1999. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol 52 : 357 362.[PubMed]
30. Loos S,, Ahlenstiel T,, Kranz B,, Staude H,, Pape L,, Hartel C,, Vester U,, Buchtala L,, Benz K,, Hoppe B,, Beringer O,, Krause M,, Muller D,, Pohl M,, Lemke J,, Hillebrand G,, Kreuzer M,, Konig J,, Wigger M,, Konrad M,, Haffner D,, Oh J,, Kemper MJ . 2012. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 55 : 753 759.[PubMed] [CrossRef]
31. Wong CS,, Mooney JC,, Brandt JR,, Staples AO,, Jelacic S,, Boster DR,, Watkins SL,, Tarr PI . 2012. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 55 : 33 41.[PubMed] [CrossRef]
32. Gasser C,, Gautier E,, Steck A,, Siebenmann RE,, Oechslin R . 1955. [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia]. Schweiz Med Wochenschr 85 : 905 909.[PubMed]
33. Fahr T, . 1925. Kreislaufstörungen in der Niere, p. 121 155. In Fahr T,, Gruber G,, Koch M,, Lubarsch O,, Stoerk O (ed.), Harnorgane Männliche Geschlechtsorgane, vol. 6. Springer, Vienna, Austria. [CrossRef]
34. Bamforth J . 1923. A case of symmetrical cortical necrosis of the kidneys occurring in an adult man. J Pathol Bacteriol 26 : 40 45.[CrossRef]
35. Campbell AC,, Henderson JL . 1949. Symmetrical cortical necrosis of the kidneys in infancy and childhood. Arch Dis Child 24 : 269 285, illust.[PubMed] [CrossRef]
36. Dunn JS,, Montgomery GL . 1941. Acute necrotising glomerulonephritis. J Pathol Bacteriol 52 : 1 16.[CrossRef]
37. Hensley WJ . 1952. Haemolytic anaemia in acute glomerulonephritis. Australas Ann Med 1 : 180 185.[PubMed]
38. Leopold SR,, Magrini V,, Holt NJ,, Shaikh N,, Mardis ER,, Cagno J,, Ogura Y,, Iguchi A,, Hayashi T,, Mellmann A,, Karch H,, Besser TE,, Sawyer SA,, Whittam TS,, Tarr PI . 2009. A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysis. Proc Natl Acad Sci USA 106 : 8713 8718.[PubMed] [CrossRef]
39. O’Brien AO,, Lively TA,, Chen ME,, Rothman SW,, Formal SB . 1983. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1 : 702. [PubMed] [CrossRef]
40. O’Brien AD,, LaVeck GD,, Thompson MR,, Formal SB . 1982. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli . J Infect Dis 146 : 763 769.[PubMed] [CrossRef]
41. Johnson WM,, Lior H,, Bezanson GS . 1983. Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet 1 : 76. [PubMed] [CrossRef]
42. O’Brien AD,, LaVeck GD . 1983. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli . Infect Immun 40 : 675 683.[PubMed]
43. Neill MA,, Tarr PI,, Clausen CR,, Christie DL,, Hickman RO . 1987. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics 80 : 37 40.[PubMed]
44. Tarr PI,, Neill MA,, Clausen CR,, Watkins SL,, Christie DL,, Hickman RO . 1990. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 162 : 553 556.[PubMed] [CrossRef]
45. Rowe PC,, Orrbine E,, Lior H,, Wells GA,, Yetisir E,, Clulow M,, McLaine PN . 1998. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. J Pediatr 132 : 777 782.[PubMed] [CrossRef]
46. Rivas M,, Miliwebsky E,, Chinen I,, Roldan CD,, Balbi L,, Garcia B,, Fiorilli G,, Sosa-Estani S,, Kincaid J,, Rangel J,, Griffin PM , Case-Control Study Group . 2006. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis 3 : 88 96.[PubMed] [CrossRef]
47. Pollock KG,, Young D,, Beattie TJ,, Todd WT . 2008. Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005. Epidemiol Infect 136 : 115 121.[PubMed] [CrossRef]
48. Hadler JL,, Clogher P,, Hurd S,, Phan Q,, Mandour M,, Bemis K,, Marcus R . 2011. Ten-year trends and risk factors for non-O157 Shiga toxin-producing Escherichia coli found through Shiga toxin testing, Connecticut, 2000–2009. Clin Infect Dis 53 : 269 276.[PubMed] [CrossRef]
49. Mody RK,, Luna-Gierke RE,, Jones TF,, Comstock N,, Hurd S,, Scheftel J,, Lathrop S,, Smith G,, Palmer A,, Strockbine N,, Talkington D,, Mahon BE,, Hoekstra RM,, Griffin PM . 2012. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli . Arch Pediatr Adolesc Med 166 : 902 909.[PubMed] [CrossRef]
50. Werber D,, Bielaszewska M,, Frank C,, Stark K,, Karch H . 2011. Watch out for the even eviler cousin-sorbitol-fermenting E coli O157. Lancet 377 : 298 299.[PubMed] [CrossRef]
51. Chapman PA,, Siddons CA . 1996. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts. J Med Microbiol 44 : 267 271.[PubMed] [CrossRef]
52. Fey PD,, Wickert RS,, Rupp ME,, Safranek TJ,, Hinrichs SH . 2000. Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6 : 530 533.[PubMed] [CrossRef]
53. Carroll KC,, Adamson K,, Korgenski K,, Croft A,, Hankemeier R,, Daly J,, Park CH . 2003. Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli . Eur J Clin Microbiol Infect Dis 22 : 689 692.[PubMed] [CrossRef]
54. Manning SD,, Madera RT,, Schneider W,, Dietrich SE,, Khalife W,, Brown W,, Whittam TS,, Somsel P,, Rudrik JT . 2007. Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001–2005. Emerg Infect Dis 13 : 318 321.[PubMed] [CrossRef]
55. Teel LD,, Daly JA,, Jerris RC,, Maul D,, Svanas G,, O’Brien AD,, Park CH . 2007. Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay. J Clin Microbiol 45 : 3377 3380.[PubMed] [CrossRef]
56. Park CH,, Kim HJ,, Hixon DL,, Bubert A . 2003. Evaluation of the duopath verotoxin test for detection of shiga toxins in cultures of human stools. J Clin Microbiol 41 : 2650 2653.[PubMed] [CrossRef]
57. Gould LH,, Bopp C,, Strockbine N,, Atkinson R,, Baselski V,, Body B,, Carey R,, Crandall C,, Hurd S,, Kaplan R,, Neill M,, Shea S,, Somsel P,, Tobin-D’Angelo M,, Griffin PM,, Gerner-Smidt P , Centers for Disease Control and Prevention (CDC) . 2009. Recommendations for diagnosis of shiga toxin–producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 58 : 1 14.[PubMed]
58. Grys TE,, Sloan LM,, Rosenblatt JE,, Patel R . 2009. Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. J Clin Microbiol 47 : 2008 2012.[PubMed] [CrossRef]
59. Vallieres E,, Saint-Jean M,, Rallu F . 2013. Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center. J Clin Microbiol 51 : 481 486.[PubMed] [CrossRef]
60. Werber D,, Mason BW,, Evans MR,, Salmon RL . 2008. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 46 : 1189 1196.[PubMed] [CrossRef]
61. Chandler WL,, Jelacic S,, Boster DR,, Ciol MA,, Williams GD,, Watkins SL,, Igarashi T,, Tarr PI . 2002. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346 : 23 32.[PubMed] [CrossRef]
62. Balestracci A,, Martin SM,, Toledo I,, Alvarado C,, Wainsztein RE . 2012. Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 27 : 1407 1410.[PubMed] [CrossRef]
63. Coad NA,, Marshall T,, Rowe B,, Taylor CM . 1991. Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol 35 : 10 16.[PubMed]
64. Oakes RS,, Siegler RL,, McReynolds MA,, Pysher T,, Pavia AT . 2006. Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117 : 1656 1662.[PubMed] [CrossRef]
65. Ojeda JM,, Kohout I,, Cuestas E . 2013. Dehydration upon admission is a risk factor for incomplete recovery of renal function in children with haemolytic uremic syndrome. Nefrologia 33 : 372 376.[PubMed]
66. Holtz LR,, Neill MA,, Tarr PI . 2009. Acute bloody diarrhea: a medical emergency for patients of all ages. Gastroenterology 136 : 1887 1898.[PubMed] [CrossRef]
67. Bell BP,, Griffin PM,, Lozano P,, Christie DL,, Kobayashi JM,, Tarr PI . 1997. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100 : E12. [PubMed] [CrossRef]
68. Cimolai N,, Basalyga S,, Mah DG,, Morrison BJ,, Carter JE . 1994. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clin Nephrol 42 : 85 89.[PubMed]
69. Misurac JM,, Knoderer CA,, Leiser JD,, Nailescu C,, Wilson AC,, Andreoli SP . 2013. Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatr 162 : 1153 1159, 1159 e1.[PubMed]
70. John CM,, Shukla R,, Jones CA . 2007. Using NSAID in volume depleted children can precipitate acute renal failure. Arch Dis Child 92 : 524 526.[PubMed] [CrossRef]
71. Havens PL,, O’Rourke PP,, Hahn J,, Higgins J,, Walker AM . 1988. Laboratory and clinical variables to predict outcome in hemolytic-uremic syndrome. Am J Dis Child 142 : 961 964.[PubMed]
72. Vitacco M,, Sanchez Avalos J,, Gianantonio CA . 1973. Heparin therapy in the hemolytic-uremic syndrome. J Pediatr 83 : 271 275.[PubMed] [CrossRef]
73. Walters MD,, Matthei IU,, Kay R,, Dillon MJ,, Barratt TM . 1989. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 3 : 130 134.[PubMed] [CrossRef]
74. Milford DV,, Staten J,, MacGreggor I,, Dawes J,, Taylor CM,, Hill FG . 1991. Prognostic markers in diarrhoea-associated haemolytic-uraemic syndrome: initial neutrophil count, human neutrophil elastase and von Willebrand factor antigen. Nephrol Dial Transplant 6 : 232 237.[PubMed] [CrossRef]
75. Balestracci A,, Martin SM,, Toledo I,, Alvarado C,, Wainsztein RE . 2014. Laboratory predictors of acute dialysis in hemolytic uremic syndrome. Pediatr Int 56 : 234 239.[PubMed] [CrossRef]
76. Dolislager D,, Tune B . 1978. The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome. Am J Dis Child 132 : 55 58.[PubMed] [CrossRef]
77. Gianantonio CA,, Vitacco M,, Mendilaharzu F,, Gallo GE,, Sojo ET . 1973. The hemolytic-uremic syndrome. Nephron 11 : 174 192.[PubMed] [CrossRef]
78. Gianantonio CA,, Vitacco M,, Mendilaharzu F,, Gallo G . 1968. The hemolytic-uremic syndrome. Renal status of 76 patients at long-term follow-up. J Pediatr 72 : 757 765.[PubMed] [CrossRef]
79. Tonshoff B,, Sammet A,, Sanden I,, Mehls O,, Waldherr R,, Scharer K . 1994. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron 68 : 63 70.[PubMed] [CrossRef]
80. Siegler RL,, Pavia AT,, Christofferson RD,, Milligan MK . 1994. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 94 : 35 40.[PubMed]
81. Mizusawa Y,, Pitcher LA,, Burke JR,, Falk MC,, Mizushima W . 1996. Survey of haemolytic-uraemic syndrome in Queensland 1979–1995. Med J Aust 165 : 188 191.[PubMed]
82. Spizzirri FD,, Rahman RC,, Bibiloni N,, Ruscasso JD,, Amoreo OR . 1997. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11 : 156 160.[PubMed] [CrossRef]
83. Mencia Bartolome S,, Martinez de Azagra A,, de Vicente Aymat A,, Monleon Luque M,, Casado Flores J . 1999. [Uremic hemolytic syndrome. Analysis of 43 cases]. An Esp Pediatr 50 : 467 470 (In Spanish).[PubMed]
84. Huseman D,, Gellermann J,, Vollmer I,, Ohde I,, Devaux S,, Ehrich JH,, Filler G . 1999. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 13 : 672 677.[PubMed] [CrossRef]
85. Loirat C . 2001. [Post-diarrhea hemolytic-uremic syndrome: clinical aspects]. Arch Pediatr 8 Suppl 4 : 776s 784s (In French).[PubMed] [CrossRef]
86. Garg AX,, Suri RS,, Barrowman N,, Rehman F,, Matsell D,, Rosas-Arellano MP,, Salvadori M,, Haynes RB,, Clark WF . 2003. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290 : 1360 1370.[PubMed] [CrossRef]
87. Oakes RS,, Kirkham JK,, Nelson RD,, Siegler RL . 2008. Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 23 : 1303 1308.[PubMed] [CrossRef]
88. Nestoridi E,, Kushak RI,, Duguerre D,, Grabowski EF,, Ingelfinger JR . 2005. Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int 67 : 2254 2266.[PubMed] [CrossRef]
89. Hughes AK,, Stricklett PK,, Kohan DE . 1998. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54 : 426 437.[PubMed] [CrossRef]
90. Taguchi T,, Uchida H,, Kiyokawa N,, Mori T,, Sato N,, Horie H,, Takeda T,, Fujimoto J . 1998. Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53 : 1681 1688.[PubMed] [CrossRef]
91. Kaneko K,, Kiyokawa N,, Ohtomo Y,, Nagaoka R,, Yamashiro Y,, Taguchi T,, Mori T,, Fujimoto J,, Takeda T . 2001. Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome. Nephron 87 : 182 185.[PubMed] [CrossRef]
92. Abuelo JG . 2007. Normotensive ischemic acute renal failure. N Engl J Med 357 : 797 805.[PubMed] [CrossRef]
93. Davis TK,, McKee R,, Schnadower D,, Tarr PI . 2013. Treatment of Shiga toxin–Producing Escherichia coli infections. Infect Dis Clin North Am 27 : 577 597.[PubMed] [CrossRef]
94. Weil BR,, Andreoli SP,, Billmire DF . 2010. Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome. Pediatr Nephrol 25 : 1693 1698.[PubMed] [CrossRef]
95. Balestracci A,, Martin SM,, Toledo I,, Alvarado C,, Wainsztein RE . 2013. Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 28 : 919 925.[PubMed] [CrossRef]
96. Schulman SL,, Kaplan BS . 1996. Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria. Pediatr Nephrol 10 : 671 674.[PubMed] [CrossRef]
97. Sutherland SM,, Zappitelli M,, Alexander SR,, Chua AN,, Brophy PD,, Bunchman TE,, Hackbarth R,, Somers MJ,, Baum M,, Symons JM,, Flores FX,, Benfield M,, Askenazi D,, Chand D,, Fortenberry JD,, Mahan JD,, McBryde K,, Blowey D,, Goldstein SL . 2010. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55 : 316 325.[PubMed] [CrossRef]
98. Kaplan BS,, Thomson PD . 1976. Hyperuricemia in the hemolytic-uremic syndrome. Am J Dis Child 130 : 854 856.[PubMed]
99. Robson WL,, Leung AK,, Brant R . 1993. Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome. Am J Nephrol 13 : 194 197.[PubMed] [CrossRef]
100. Proesmans W,, VanCauter A,, Thijs L,, Lijnen P . 1994. Plasma renin activity in haemolytic uraemic syndrome. Pediatr Nephrol 8 : 444 446.[PubMed] [CrossRef]
101. Katz J,, Krawitz S,, Sacks PV,, Levin SE,, Thomson P,, Levin J,, Metz J . 1973. Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancy. J Pediatr 83 : 739 748.[PubMed] [CrossRef]
102. Nakahata T,, Tanaka H,, Tateyama T,, Ueda T,, Suzuki K,, Osari S,, Kasai M,, Waga S . 2001. Thrombotic stroke in a child with diarrhea-associated hemolytic-uremic syndrome with a good recovery. Tohoku J Exp Med 193 : 73 77.[PubMed] [CrossRef]
103. Trevathan E,, Dooling EC . 1987. Large thrombotic strokes in hemolytic-uremic syndrome. J Pediatr 111 : 863 866.[PubMed] [CrossRef]
104. Steinborn M,, Leiz S,, Rudisser K,, Griebel M,, Harder T,, Hahn H . 2004. CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 34 : 805 810.[PubMed] [CrossRef]
105. Nathanson S,, Kwon T,, Elmaleh M,, Charbit M,, Launay EA,, Harambat J,, Brun M,, Ranchin B,, Bandin F,, Cloarec S,, Bourdat-Michel G,, Pietrement C,, Champion G,, Ulinski T,, Deschenes G . 2010. Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5 : 1218 1228.[PubMed] [CrossRef]
106. Weissenborn K,, Donnerstag F,, Kielstein JT,, Heeren M,, Worthmann H,, Hecker H,, Schmitt R,, Schiffer M,, Pasedag T,, Schuppner R,, Tryc AB,, Raab P,, Hartmann H,, Ding XQ,, Hafer C,, Menne J,, Schmidt BM,, Bultmann E,, Haller H,, Dengler R,, Lanfermann H,, Giesemann AM . 2012. Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults. Neurology 79 : 1466 1473.[PubMed] [CrossRef]
107. Signorini E,, Lucchi S,, Mastrangelo M,, Rapuzzi S,, Edefonti A,, Fossali E . 2000. Central nervous system involvement in a child with hemolytic uremic syndrome. Pediatr Nephrol 14 : 990 992.[PubMed] [CrossRef]
108. Steele BT,, Murphy N,, Chuang SH,, McGreal D,, Arbus GS . 1983. Recovery from prolonged coma in hemolytic uremic syndrome. J Pediatr 102 : 402 404.[PubMed] [CrossRef]
109. Steinberg A,, Ish-Horowitcz M,, el-Peleg O,, Mor J,, Branski D . 1986. Stroke in a patient with hemolytic-uremic syndrome with a good outcome. Brain Dev 8 : 70 72.[PubMed] [CrossRef]
110. Kahn SI,, Tolkan SR,, Kothari O,, Garella S . 1982. Spontaneous recovery of the hemolytic uremic syndrome with prolonged renal and neurological manifestations. Nephron 32 : 188 191.[PubMed] [CrossRef]
111. Magnus T,, Rother J,, Simova O,, Meier-Cillien M,, Repenthin J,, Moller F,, Gbadamosi J,, Panzer U,, Wengenroth M,, Hagel C,, Kluge S,, Stahl RK,, Wegscheider K,, Urban P,, Eckert B,, Glatzel M,, Fiehler J,, Gerloff C . 2012. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135 : 1850 1859.[PubMed] [CrossRef]
112. Braune SA,, Wichmann D,, von Heinz MC,, Nierhaus A,, Becker H,, Meyer TN,, Meyer GP,, Muller-Schulz M,, Fricke J,, de Weerth A,, Hoepker WW,, Fiehler J,, Magnus T,, Gerloff C,, Panzer U,, Stahl RA,, Wegscheider K,, Kluge S . 2013. Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome. Crit Care Med 41 : 1702 1710.[PubMed] [CrossRef]
113. Murphy EJ . 2005. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 33 : 311 322.[PubMed]
114. Niscola P,, Scaramucci L,, Vischini G,, Giovannini M,, Ferrannini M,, Massa P,, Tatangelo P,, Galletti M,, Palumbo R . 2010. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets 11 : 752 758.[PubMed] [CrossRef]
115. Lapeyraque AL,, Malina M,, Fremeaux-Bacchi V,, Boppel T,, Kirschfink M,, Oualha M,, Proulx F,, Clermont MJ,, Le Deist F,, Niaudet P,, Schaefer F . 2011. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364 : 2561 2563.[PubMed] [CrossRef]
116. Orth D,, Khan AB,, Naim A,, Grif K,, Brockmeyer J,, Karch H,, Joannidis M,, Clark SJ,, Day AJ,, Fidanzi S,, Stoiber H,, Dierich MP,, Zimmerhackl LB,, Wurzner R . 2009. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 182 : 6394 6400.[PubMed] [CrossRef]
117. Morigi M,, Galbusera M,, Gastoldi S,, Locatelli M,, Buelli S,, Pezzotta A,, Pagani C,, Noris M,, Gobbi M,, Stravalaci M,, Rottoli D,, Tedesco F,, Remuzzi G,, Zoja C . 2011. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 187 : 172 180.[PubMed] [CrossRef]
118. Stahl AL,, Sartz L,, Karpman D . 2011. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117 : 5503 5513.[PubMed] [CrossRef]
119. Lopez EL,, Contrini MM,, Glatstein E,, Ayala SG,, Santoro R,, Ezcurra G,, Teplitz E,, Matsumoto Y,, Sato H,, Sakai K,, Katsuura Y,, Hoshide S,, Morita T,, Harning R,, Brookman S . 2012. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. Pediatr Infect Dis J 31 : 20 24.[PubMed] [CrossRef]
120. Lee BC,, Mayer CL,, Leibowitz CS,, Stearns-Kurosawa DJ,, Kurosawa S . 2013. Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathy. Blood 122 : 803 806.[PubMed] [CrossRef]
121. Thurman JM,, Marians R,, Emlen W,, Wood S,, Smith C,, Akana H,, Holers VM,, Lesser M,, Kline M,, Hoffman C,, Christen E,, Trachtman H . 2009. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4 : 1920 1924.[PubMed] [CrossRef]
122. Ganter MT,, Brohi K,, Cohen MJ,, Shaffer LA,, Walsh MC,, Stahl GL,, Pittet JF . 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28 : 29 34.[PubMed] [CrossRef]
123. Römer S,, Schaumburg R,, Karch H,, Schwindt W,, Waltenberger J,, Lebiedz P . 2012. Septic shock and ARDS after Eculizumab application in Shiga-toxin associated HUS during the outbreak of Shiga toxin-producing enterohaemorrhagic E. coli O104:H4. Medizinische Klinik, Intensivmedizin und Notfallmedizin 107 : 329 330.
124. Tarr PI . 2009. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int Suppl : S29 S32. [PubMed] [CrossRef]
125. Colic E,, Dieperink H,, Titlestad K,, Tepel M . 2011. Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 378 : 1089 1093.[PubMed] [CrossRef]
126. Veyradier A,, Obert B,, Haddad E,, Cloarec S,, Nivet H,, Foulard M,, Lesure F,, Delattre P,, Lakhdari M,, Meyer D,, Girma JP,, Loirat C . 2003. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr 142 : 310 317.[PubMed] [CrossRef]
127. Kielstein JT,, Beutel G,, Fleig S,, Steinhoff J,, Meyer TN,, Hafer C,, Kuhlmann U,, Bramstedt J,, Panzer U,, Vischedyk M,, Busch V,, Ries W,, Mitzner S,, Mees S,, Stracke S,, Nurnberger J,, Gerke P,, Wiesner M,, Sucke B,, Abu-Tair M,, Kribben A,, Klause N,, Schindler R,, Merkel F,, Schnatter S,, Dorresteijn EM,, Samuelsson O,, Brunkhorst R , Collaborators of the DGfN STEC-HUS registry . 2012. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27 : 3807 3815.[PubMed] [CrossRef]
128. Samuelsson O,, Follin P,, Rundgren M,, Rylander C,, Selga D,, Stahl A . 2012. [The HUS epidemic in the summer of 2011 was severe. German and Swedish experiences of the EHEC outbreak]. Lakartidningen 109 : 1230 1234 (In Swedish).[PubMed]
129. Nitschke M,, Sayk F,, Hartel C,, Roseland RT,, Hauswaldt S,, Steinhoff J,, Fellermann K,, Derad I,, Wellhoner P,, Buning J,, Tiemer B,, Katalinic A,, Rupp J,, Lehnert H,, Solbach W,, Knobloch JK . 2012. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 307 : 1046 1052.[PubMed] [CrossRef]
130. Som S,, Deford CC,, Kaiser ML,, Terrell DR,, Kremer Hovinga JA,, Lammle B,, George JN,, Vesely SK . 2012. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion 52 : 2525 2532; quiz 2524.[PubMed] [CrossRef]
131. Havens PL,, Hoffman GM,, Shith KJ . 1989. The homogeneous nature of the hemolytic uremic syndrome. Clin Pediatr (Phila) 28 : 482 483.[PubMed] [CrossRef]
132. Kaplan BS,, Chesney RW,, Drummond KN . 1975. Hemolytic uremic syndrome in families. N Engl J Med 292 : 1090 1093.[PubMed] [CrossRef]
133. Karpac CA,, Li X,, Terrell DR,, Kremer Hovinga JA,, Lammle B,, Vesely SK,, George JN . 2008. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol 141 : 696 707.[PubMed] [CrossRef]
134. Geerdink LM,, Westra D,, van Wijk JA,, Dorresteijn EM,, Lilien MR,, Davin JC,, Komhoff M,, Van Hoeck K,, van der Vlugt A,, van den Heuvel LP,, van de Kar NC . 2012. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 27 : 1283 1291.[PubMed] [CrossRef]
135. Noris M,, Caprioli J,, Bresin E,, Mossali C,, Pianetti G,, Gamba S,, Daina E,, Fenili C,, Castelletti F,, Sorosina A,, Piras R,, Donadelli R,, Maranta R,, van der Meer I,, Conway EM,, Zipfel PF,, Goodship TH,, Remuzzi G . 2010. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5 : 1844 1859.[PubMed] [CrossRef]
136. Westra D,, Wetzels JF,, Volokhina EB,, van den Heuvel LP,, van de Kar NC . 2012. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med 70 : 121 129.[PubMed]
137. Ariceta G,, Besbas N,, Johnson S,, Karpman D,, Landau D,, Licht C,, Loirat C,, Pecoraro C,, Taylor CM,, Van de Kar N,, Vandewalle J,, Zimmerhackl LB , European Paediatric Study Group for HUS . 2009. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24 : 687 696.[PubMed] [CrossRef]
138. Espie E,, Grimont F,, Mariani-Kurkdjian P,, Bouvet P,, Haeghebaert S,, Filliol I,, Loirat C,, Decludt B,, Minh NN,, Vaillant V,, de Valk H . 2008. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J 27 : 595 601.[PubMed] [CrossRef]
139. Chart H,, Cheasty T . 2008. Human infections with verocytotoxin-producing Escherichia coli O157—10 years of E. coli O157 serodiagnosis. J Med Microbiol 57 : 1389 1393.[PubMed] [CrossRef]
140. Fernandez-Brando RJ,, Bentancor LV,, Mejias MP,, Ramos MV,, Exeni A,, Exeni C,, Laso Mdel C,, Exeni R,, Isturiz MA,, Palermo MS . 2011. Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods. PLoS One 6 : e19136. [PubMed] [CrossRef]
141. Close RM,, Ejidokun OO,, Verlander NQ,, Fraser G,, Meltzer M,, Rehman Y,, Muir P,, Ninis N,, Stuart JM . 2011. Early diagnosis model for meningitis supports public health decision making. J Infect 63 : 32 38.[PubMed] [CrossRef]
142. Bokete TN,, O’Callahan CM,, Clausen CR,, Tang NM,, Tran N,, Moseley SL,, Fritsche TR,, Tarr PI . 1993. Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective study. Gastroenterology 105 : 1724 1731.[PubMed]
143. Carter AO,, Borczyk AA,, Carlson JA,, Harvey B,, Hockin JC,, Karmali MA,, Krishnan C,, Korn DA,, Lior H . 1987. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 317 : 1496 1500.[PubMed] [CrossRef]
144. Pavia AT,, Nichols CR,, Green DP,, Tauxe RV,, Mottice S,, Greene KD,, Wells JG,, Siegler RL,, Brewer ED,, Hannon D . 1990. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 116 : 544 551.[PubMed] [CrossRef]
145. Proulx F,, Turgeon JP,, Delage G,, Lafleur L,, Chicoine L . 1992. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 121 : 299 303.[PubMed] [CrossRef]
146. Wong CS,, Jelacic S,, Habeeb RL,, Watkins SL,, Tarr PI . 2000. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342 : 1930 1936.[PubMed] [CrossRef]
147. Dundas S,, Todd WT,, Stewart AI,, Murdoch PS,, Chaudhuri AK,, Hutchinson SJ . 2001. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 33 : 923 931.[PubMed] [CrossRef]
148. Smith KE,, Wilker PR,, Reiter PL,, Hedican EB,, Bender JB,, Hedberg CW . 2012. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J 31 : 37 41.[PubMed] [CrossRef]
149. Grisaru S,, Morgunov MA,, Samuel SM,, Midgley JP,, Wade AW,, Tee JB,, Hamiwka LA . 2011. Acute renal replacement therapy in children with diarrhea-associated hemolytic uremic syndrome: a single center 16 years of experience. Int J Nephrol 2011 : 930539. [PubMed] [CrossRef]
150. Adragna M,, Balestracci A,, Garcia Chervo L,, Steinbrun S,, Delgado N,, Briones L . 2012. Acute dialysis-associated peritonitis in children with D+ hemolytic uremic syndrome. Pediatr Nephrol 27 : 637 642.[PubMed] [CrossRef]
151. Grodinsky S,, Telmesani A,, Robson WL,, Fick G,, Scott RB . 1990. Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr 11 : 518 524.[PubMed] [CrossRef]
152. Brandt JR,, Joseph MW,, Fouser LS,, Tarr PI,, Zelikovic I,, McDonald RA,, Avner ED,, McAfee NG,, Watkins SL . 1998. Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12 : 222 225.[PubMed] [CrossRef]
153. Schweighofer S Jr,, Primack WA,, Slovis TL,, Fleischmann LE,, Slovis TL,, Hight DW . 1980. Cholelithiasis associated with the hemolytic-uremic syndrome. Am J Dis Child 134 : 622. [PubMed]
154. Suri RS,, Mahon JL,, Clark WF,, Moist LM,, Salvadori M,, Garg AX . 2009. Relationship between Escherichia coli O157:H7 and diabetes mellitus. Kidney Int Suppl : S44 S46.[PubMed] [CrossRef]
155. US Census Bureau . 2010. 2010 Census Population and Housing Tables (CPH-Ts). http://quickfacts.census.gov/qfd/states/00000.html. Accessed on June 18, 2014.
156. Suri RS,, Clark WF,, Barrowman N,, Mahon JL,, Thiessen-Philbrook HR,, Rosas-Arellano MP,, Zarnke K,, Garland JS,, Garg AX . 2005. Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis. Diabetes Care 28 : 2556 2562.[PubMed] [CrossRef]
157. Andreoli SP,, Bergstein JM . 1982. Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome. J Pediatr 100 : 541 545.[PubMed] [CrossRef]
158. Tapper D,, Tarr P,, Avner E,, Brandt J,, Waldhausen J . 1995. Lessons learned in the management of hemolytic uremic syndrome in children. J Pediatr Surg 30 : 158 163.[PubMed] [CrossRef]
159. Dundas S,, Todd WT . 2000. Clinical presentation, complications and treatment of infection with verocytotoxin-producing Escherichia coli. Challenges for the clinician. Symp Ser Soc Appl Microbiol : 24S 30S.[PubMed] [CrossRef]
160. Whitington PF,, Friedman AL,, Chesney RW . 1979. Gastrointestinal disease in the hemolytic-uremic syndrome. Gastroenterology 76 : 728 733.[PubMed]
161. Yates RS,, Osterholm RK . 1980. Hemolytic-uremic syndrome colitis. J Clin Gastroenterol 2 : 359 363.[PubMed] [CrossRef]
162. Sawaf H,, Sharp MJ,, Youn KJ,, Jewell PA,, Rabbani A . 1978. Ischemic colitis and stricture after hemolytic-uremic syndrome. Pediatrics 61 : 315 317.[PubMed]
163. Abu-Arafeh I,, Gray E,, Youngson G,, Auchterlonie I,, Russell G . 1995. Myocarditis and haemolytic uraemic syndrome. Arch Dis Child 72 : 46 47.[PubMed] [CrossRef]
164. Sturm V,, Menke MN,, Landau K,, Laube GF,, Neuhaus TJ . 2010. Ocular involvement in paediatric haemolytic uraemic syndrome. Acta Ophthalmol 88 : 804 807.[PubMed] [CrossRef]
165. Siegler RL,, Brewer ED,, Swartz M . 1988. Ocular involvement in hemolytic-uremic syndrome. J Pediatr 112 : 594 597.[PubMed] [CrossRef]
166. Manton N,, Smith NM,, Byard RW . 2000. Unexpected childhood death due to hemolytic uremic syndrome. Am J Forensic Med Pathol 21 : 90 92.[PubMed] [CrossRef]
167. Robson WL,, Leung AK,, Montgomery MD . 1991. Causes of death in hemolytic uremic syndrome. Child Nephrol Urol 11 : 228 233.[PubMed]

Tables

Generic image for table
TABLE 1

Acuity pyramid

Citation: Davis T, van De Kar N, Tarr P. 2015. Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives, p 321-339. In Sperandio V, Hovde C (ed), Enterohemorrhagic and Other Shiga Toxin-Producing . ASM Press, Washington, DC. doi: 10.1128/microbiolspec.EHEC-0025-2014
Generic image for table
TABLE 2

Summary of antibiotic experience in multiple case control studies of children and adults

Citation: Davis T, van De Kar N, Tarr P. 2015. Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives, p 321-339. In Sperandio V, Hovde C (ed), Enterohemorrhagic and Other Shiga Toxin-Producing . ASM Press, Washington, DC. doi: 10.1128/microbiolspec.EHEC-0025-2014
Generic image for table
TABLE 3

Severity of HUS in series identified in PubMed published between 2009 and 2013, using search terms hemolytic-uremic syndrome AND children, on September 4, 2013

Citation: Davis T, van De Kar N, Tarr P. 2015. Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives, p 321-339. In Sperandio V, Hovde C (ed), Enterohemorrhagic and Other Shiga Toxin-Producing . ASM Press, Washington, DC. doi: 10.1128/microbiolspec.EHEC-0025-2014
Generic image for table
TABLE 4

Selected nonnephrologic, nonhematologic complications of HUS

Citation: Davis T, van De Kar N, Tarr P. 2015. Shiga Toxin/Verocytotoxin-Producing Infections: Practical Clinical Perspectives, p 321-339. In Sperandio V, Hovde C (ed), Enterohemorrhagic and Other Shiga Toxin-Producing . ASM Press, Washington, DC. doi: 10.1128/microbiolspec.EHEC-0025-2014

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error